Sun.Oct 09, 2022

article thumbnail

Novel cancer therapeutic synthesised by Stanford researchers

European Pharmaceutical Review

Research published in the journal Nature Chemistry , shows how researchers from Stanford University in the US uncovered a promising new method to synthetically manufacture the compound tigilanol tiglate, named EBC-46, which could offer targeted medicine for cancer and other diseases. Natural sources of the compound can only be found in a small section of the Northeastern Australia rainforest, in fruit seeds from the blushwood tree ( Fontainea picrosperma ).

article thumbnail

PureTech confirms negotiations for a possible Nektar merger

pharmaphorum

Rumours that Nektar Therapeutics may be talking about a merger with healthcare holding company PureTech have been confirmed by the two companies. UK-based PureTech – which develops its own therapies and also has interests in a wide range of companies including digital health players Akili and Sonde as well as drug developers Vedanta, Gelesis and Follica – said it has “exchanged indicative, non-binding proposals” with Nektar that have no guarantee of leading to a deal.

Leads 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Aurobindo Pharma-Openings for B.Tech/ Diploma in Engineering OSD Dept.-Apply Now

Pharma Pathway

Aurobindo Pharma-Openings for B.Tech/ Diploma in Engineering OSD Dept.-Apply Now. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations.

article thumbnail

Discover how to optimize the Gibco Efficient-Pro system for your process

PharmaTech

Improve process productivity and performance with the state-of-the-art Gibco™ Efficient?Pro™ Medium and feed system. Formulated to work in perfect harmony, the system comprises the high-performance Efficient-Pro Medium and a choice of two premium feeds—Gibco™ Efficient-Pro™ Feed 1 for CHO-K1 cells and Gibco™ Efficient-Pro™ Feed 2 for CHO-S, CHO-GS, and CHO-DG44 cells.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Mangalam Drugs & Organics Ltd. -Job Opening for R&D Department -Apply Now

Pharma Pathway

Mangalam Drugs & Organics Ltd. -Job Opening for R&D Department -Apply Now. Job Description. Job Opening for R&D -Apply Now at Mangalam Drugs And Organics Ltd, Vapi , Unit II. Department: R&D. Designation: Chemist to Officer. Qualification: B.Sc/ M.Sc (Chemist). Experience: 02 to 05 years ( API Only). Job Location: Vapi, Gujarat. No of Requirements: 15.

52
article thumbnail

How Can Pharma Solve the Affordability Puzzle?

Pharmaceutical Commerce

undefined.

Pharma 52